208 related articles for article (PubMed ID: 26108672)
21. Changing incidence and improved survival of gliomas.
Ho VK; Reijneveld JC; Enting RH; Bienfait HP; Robe P; Baumert BG; Visser O;
Eur J Cancer; 2014 Sep; 50(13):2309-18. PubMed ID: 24972545
[TBL] [Abstract][Full Text] [Related]
22. Radiotherapy in supratentorial gliomas. A study of 821 cases.
Heesters M; Molenaar W; Go GK
Strahlenther Onkol; 2003 Sep; 179(9):606-14. PubMed ID: 14628126
[TBL] [Abstract][Full Text] [Related]
23. WT1 expression increases with malignancy and indicates unfavourable outcome in astrocytoma.
Rauscher J; Beschorner R; Gierke M; Bisdas S; Braun C; Ebner FH; Schittenhelm J
J Clin Pathol; 2014 Jul; 67(7):556-61. PubMed ID: 24607494
[TBL] [Abstract][Full Text] [Related]
24. Quantitative proteomic analysis and functional studies reveal that nucleophosmin is involved in cell death in glioblastoma cell line transfected with siRNA.
Gimenez M; Marie SK; Oba-Shinjo SM; Uno M; da Silva R; Laure HJ; Izumi C; Otake A; Chammas R; Rosa JC
Proteomics; 2012 Aug; 12(17):2632-40. PubMed ID: 22745010
[TBL] [Abstract][Full Text] [Related]
25. Expression of non-glial intermediate filament proteins in gliomas.
Hirato J; Nakazato Y; Ogawa A
Clin Neuropathol; 1994; 13(1):1-11. PubMed ID: 7518371
[TBL] [Abstract][Full Text] [Related]
26. Expression of the genes encoding myelin basic protein and proteolipid protein in human malignant gliomas.
Golfinos JG; Norman SA; Coons SW; Norman RA; Ballecer C; Scheck AC
Clin Cancer Res; 1997 May; 3(5):799-804. PubMed ID: 9815752
[TBL] [Abstract][Full Text] [Related]
27. YKL-40 is directly produced by tumor cells and is inversely linked to EGFR in glioblastomas.
Horbinski C; Wang G; Wiley CA
Int J Clin Exp Pathol; 2010 Jan; 3(3):226-37. PubMed ID: 20224722
[TBL] [Abstract][Full Text] [Related]
28. A unique four-hub protein cluster associates to glioblastoma progression.
Simeone P; Trerotola M; Urbanella A; Lattanzio R; Ciavardelli D; Di Giuseppe F; Eleuterio E; Sulpizio M; Eusebi V; Pession A; Piantelli M; Alberti S
PLoS One; 2014; 9(7):e103030. PubMed ID: 25050814
[TBL] [Abstract][Full Text] [Related]
29. [OMICS and biomarkers of glial tumors].
Idbaih A
Rev Neurol (Paris); 2011 Oct; 167(10):691-8. PubMed ID: 21889780
[TBL] [Abstract][Full Text] [Related]
30. Aurora A is differentially expressed in gliomas, is associated with patient survival in glioblastoma and is a potential chemotherapeutic target in gliomas.
Lehman NL; O'Donnell JP; Whiteley LJ; Stapp RT; Lehman TD; Roszka KM; Schultz LR; Williams CJ; Mikkelsen T; Brown SL; Ecsedy JA; Poisson LM
Cell Cycle; 2012 Feb; 11(3):489-502. PubMed ID: 22274399
[TBL] [Abstract][Full Text] [Related]
31. Proteomic Characterization of Annexin l (ANX1) and Heat Shock Protein 27 (HSP27) as Biomarkers for Invasive Hepatocellular Carcinoma Cells.
Wang RC; Huang CY; Pan TL; Chen WY; Ho CT; Liu TZ; Chang YJ
PLoS One; 2015; 10(10):e0139232. PubMed ID: 26431426
[TBL] [Abstract][Full Text] [Related]
32. Gene expression-based molecular diagnostic system for malignant gliomas is superior to histological diagnosis.
Shirahata M; Iwao-Koizumi K; Saito S; Ueno N; Oda M; Hashimoto N; Takahashi JA; Kato K
Clin Cancer Res; 2007 Dec; 13(24):7341-56. PubMed ID: 18094416
[TBL] [Abstract][Full Text] [Related]
33. [Changes of folate receptor -α protein expression in human gliomas and its clinical relevance].
Wu H; Zhan Y; Qu Y; Qi X; Li J; Yu C
Zhonghua Wai Ke Za Zhi; 2014 Mar; 52(3):202-7. PubMed ID: 24785460
[TBL] [Abstract][Full Text] [Related]
34. CD40/CD40L expression correlates with the survival of patients with glioblastomas and an augmentation in CD40 signaling enhances the efficacy of vaccinations against glioma models.
Chonan M; Saito R; Shoji T; Shibahara I; Kanamori M; Sonoda Y; Watanabe M; Kikuchi T; Ishii N; Tominaga T
Neuro Oncol; 2015 Nov; 17(11):1453-62. PubMed ID: 26008605
[TBL] [Abstract][Full Text] [Related]
35. Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas.
Geiger KD; Stoldt P; Schlote W; Derouiche A
Am J Pathol; 2000 Dec; 157(6):1785-93. PubMed ID: 11106550
[TBL] [Abstract][Full Text] [Related]
36. Gene co-expression network and function modules in three types of glioma.
Li G; Pan W; Yang X; Miao J
Mol Med Rep; 2015 Apr; 11(4):3055-63. PubMed ID: 25435164
[TBL] [Abstract][Full Text] [Related]
37. [An immunohistochemical and ultrastructural study of 243 gliomas with reference to the prognosis].
Bian XW
Zhonghua Bing Li Xue Za Zhi; 1992 Jun; 21(3):171-3. PubMed ID: 1335846
[TBL] [Abstract][Full Text] [Related]
38. Proteomic analysis of oligodendrogliomas expressing a mutant isocitrate dehydrogenase-1.
Thirant C; Varlet P; Lipecka J; Le Gall M; Broussard C; Chafey P; Studler JM; Lacombe J; Lions S; Guillaudeau A; Camoin L; Daumas-Duport C; Junier MP; Chneiweiss H
Proteomics; 2011 Nov; 11(21):4139-54. PubMed ID: 21898821
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of ABCA2' a possible molecular marker for oligodendrogliomas.
Soichi O; Masanori N; Hideo T; Kazunori A; Nobuya I; Jun-ichi K
Neurosurgery; 2007 Apr; 60(4):707-14; discussion 714. PubMed ID: 17415208
[TBL] [Abstract][Full Text] [Related]
40. Tenascin-C: a novel candidate marker for cancer stem cells in glioblastoma identified by tissue microarrays.
Nie S; Gurrea M; Zhu J; Thakolwiboon S; Heth JA; Muraszko KM; Fan X; Lubman DM
J Proteome Res; 2015 Feb; 14(2):814-22. PubMed ID: 25469866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]